| scholarly article | Q13442814 |
| P50 | author | Flavio Rizzolio | Q57544256 |
| Carol F Lippa | Q87962401 | ||
| Yuesong Gong | Q87962404 | ||
| P2093 | author name string | Tongzheng Liu | |
| Shaohui Huang | |||
| Richard Tsai | |||
| Yungen Xu | |||
| Lingyan Xu | |||
| Silvia Boffo | |||
| Frances E Chow | |||
| Zhiyun Ren | |||
| P2860 | cites work | Memory and mental status correlates of modified Braak staging. | Q52170951 |
| PIN1, the cell cycle and cancer. | Q53561253 | ||
| The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein | Q22010198 | ||
| A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease | Q22241518 | ||
| Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond | Q22251042 | ||
| The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production | Q24309767 | ||
| Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins | Q24329069 | ||
| Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders | Q24337114 | ||
| Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism | Q24530210 | ||
| Shank3 mutant mice display autistic-like behaviours and striatal dysfunction | Q24597501 | ||
| Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses | Q24619395 | ||
| Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism | Q24620573 | ||
| Rapamycin fed late in life extends lifespan in genetically heterogeneous mice | Q24647805 | ||
| Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation | Q27934506 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein | Q28198177 | ||
| Phosphorylation-specific prolyl isomerization: is there an underlying theme? | Q28248256 | ||
| Identification of novel phosphorylation sites on postsynaptic density proteins | Q28281343 | ||
| Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression | Q28566984 | ||
| Prolyl isomerase Pin1 regulates neuronal differentiation via β-catenin | Q28586339 | ||
| Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine | Q29465775 | ||
| Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis | Q29547501 | ||
| Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins | Q29547593 | ||
| Alzheimer's disease is a synaptic failure | Q29547670 | ||
| Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system | Q29617400 | ||
| Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques | Q30486499 | ||
| PIN1 gene variants in Alzheimer's disease | Q30883650 | ||
| Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation | Q30885629 | ||
| Comprehensive identification of phosphorylation sites in postsynaptic density preparations | Q33232861 | ||
| Phosphorylation stabilizes Nanog by promoting its interaction with Pin1 | Q34068097 | ||
| Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders | Q34138025 | ||
| Pin1 and PKMzeta sequentially control dendritic protein synthesis | Q34274733 | ||
| Alzheimer disease therapy: can the amyloid cascade be halted? | Q34828328 | ||
| Association of membrane rafts and postsynaptic density: proteomics, biochemical, and ultrastructural analyses | Q35249037 | ||
| Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss | Q35918370 | ||
| Extracellular level of GABA and Glu: in vivo microdialysis-HPLC measurements | Q36512995 | ||
| The postsynaptic density | Q36545830 | ||
| Pin1 in Alzheimer's disease | Q36582738 | ||
| The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease | Q36945537 | ||
| Extracellular glutamate concentration in hippocampal slice | Q37163189 | ||
| Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias | Q37790804 | ||
| Preventing Alzheimer's disease | Q39549596 | ||
| Amyloid peptide attenuates the proteasome activity in neuronal cells | Q40375322 | ||
| Neurotransmitters drive combinatorial multistate postsynaptic density networks. | Q41184685 | ||
| Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability | Q41892623 | ||
| Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease | Q42558615 | ||
| Characterization of the proteome, diseases and evolution of the human postsynaptic density. | Q42610204 | ||
| Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. | Q44532915 | ||
| Postsynaptic density assembly is fundamentally different from presynaptic active zone assembly. | Q44762697 | ||
| Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. | Q46425942 | ||
| Protein Never in Mitosis Gene A Interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells | Q46466667 | ||
| Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. | Q47763676 | ||
| Continual remodeling of postsynaptic density and its regulation by synaptic activity | Q48128407 | ||
| Diagnostic criteria for neuropathologic assessment of Alzheimer's disease | Q48662480 | ||
| Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis | Q48858833 | ||
| A rapid method for preparing synaptosomes: comparison, with alternative procedures | Q49135145 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| synaptic plasticity | Q1551556 | ||
| Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | Q21116190 | ||
| P304 | page(s) | 3270725 | |
| P577 | publication date | 2017-03-26 | |
| P1433 | published in | Neural Plasticity | Q15716605 |
| P1476 | title | Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease | |
| P478 | volume | 2017 |
| Q89972068 | Downregulation of miR-33 Has Protective Effect Against Aβ₂₅₋₃₅-Induced Injury in SH-SH-SY5Y Cells |
| Q90722392 | Liraglutide Treatment Ameliorates Neurotoxicity Induced by Stable Silencing of Pin1 |
| Q97521007 | Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues? |
| Q96155773 | Peptidyl-Prolyl Cis/Trans Isomerase Pin1 and Alzheimer's Disease |
| Q58795095 | Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes? |
| Q59812522 | Prolyl Isomerase Pin1 Directly Regulates Calcium/Calmodulin-Dependent Protein Kinase II Activity in Mouse Brains |
Search more.